Clinical Research Directory

Tumor Regression Grade As Predictor of Adjuvant Therapy

Sponsor: Fujian Medical University Union Hospital

Summary

Neoadjuvant therapy followed by surgery is preferred for locally advanced esophageal squamous cell carcinoma, but the necessity of adjuvant therapy remains controversial. Tumor regression grade reflects the response to neoadjuvant therapy and may predict patient prognosis, yet its role in guiding adjuvant therapy remains unexplored.

Official title: Tumor Regression Grade As Predictor of Adjuvant Therapy Benefits in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy

Key Details

Conditions

Interventions

Locations (1)